RCT | Impact of empagliflozin on decongestion in acute heart failure.

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial – European Heart Journal

Commentary: Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE – American College of Cardiology

Commentary on Twitter

What's the impact of empagliflozin on decongestion in acute heart failure? New insights from the EMPULSE trial in EHJ!https://t.co/O1MZTFPWCc#SGLT2 #decongestion #heartfailure #empagliflozin #cardiotwitter @escardio @ESC_Journals pic.twitter.com/QLJYNgl1Zo

— EHJ Editor-in-Chief (@ehj_ed) October 19, 2022

Under a https://creativecommons.org/licenses/by-nc/4.0/ license